PATENT CLAIM ANALYSIS

Application Number: 15910988
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The disclosure relates to polypeptides and pharmaceutical compositions comprising polypeptides that find use in the prevention or treatment of cancer, in particular breast cancer, ovarian cancer and colorectal cancer. The disclosure also relates to methods of inducing a cytotoxic T cell response in a subject or treating cancer by administering pharmaceutical compositions comprising the peptides, and companion diagnostic methods of identifying subjects for treatment. The peptides comprise T cell epitopes that are immunogenic in a high percentage of patients.

Claim (Index 5):
The pharmaceutical composition of  claim 1 , comprising six peptides, wherein each peptide comprises a different one of the amino acid sequences of SEQ ID NOs: 121, 124, 126, 130, 131, and 134.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.7
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14766685', '14424702', '13993291', '12967606', '10543755']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.747804067530609
- 35 USC 102 Novelty (BERT): 0.5287713225804056
- Combined Prediction Score: 0.7259007930355887
- Mean Citation Score: 348.740696
- Max Citation Score: 354.5367
- Similarity Product: 234.1135216303825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test